Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Clinical trial NCT00126555 · COMPLETED

Trial details

NCT number: NCT00126555
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Skin Cancer Squamous Cell Carcinoma of the Skin

Start date: 2005-03-01
Primary completion: 2013-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.